Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 81(23): 12758-65, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17898056

ABSTRACT

Whole genome phylogenetic analysis in this study resolved a total of five major genotypes among the 22 varicella-zoster virus (VZV) strains or isolates for which complete genomic sequences are available. Consistent with earlier publications we have designated these genotypes European 1 (E1), European 2 (E2), Japanese (J), mosaic 1 (M1), and mosaic 2 (M2). Single nucleotide polymorphism (SNP) analysis performed in a whole-genome alignment revealed that VZV isolates of all five genotypes can be accurately genotyped using SNPs from two amplicons: open reading frame 22 (ORF22) and either ORF21 or ORF50. This modified approach identifies all of the genotypes observed using any of the published genotyping protocols. Of 165 clinical varicella and zoster isolates from Australia and New Zealand typed using this approach, 67 of 127 eastern Australian isolates were E1, 30 were E2, 16 were J, 10 were M1, and 4 were M2; 25 of 38 New Zealand isolates were E1, 8 were E2, and 5 were M1. VZV strain diversity in eastern Australia is thus broader than has been described for any other region, including Europe, Africa, and North America. J strains were far more prevalent than previously observed in countries other than Japan. Two-amplicon typing was in complete accord with genotypes derived using SNP in multiple ORFs (ORFs 1, 21, 22, 38, 50, 54, and 62). Two additional minor genotypes, M3 and M4, could also be resolved using two-amplicon typing.


Subject(s)
Genetic Techniques , Herpesvirus 3, Human/classification , Herpesvirus 3, Human/genetics , Polymorphism, Single Nucleotide , Australia , DNA, Viral/genetics , Genome, Viral/genetics , Genotype , Herpes Zoster/virology , Herpesvirus 3, Human/isolation & purification , Humans , Molecular Epidemiology , New Zealand , Open Reading Frames , Phylogeny , Sensitivity and Specificity , Sequence Homology
3.
Infect Control Hosp Epidemiol ; 26(8): 720-5, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16156330

ABSTRACT

OBJECTIVE: To assess the efficacy of a standard cleaning and sterilization protocol employed during reuse of cardiac electrophysiology catheters on the infectivity of duck hepatitis B virus (DHBV; a surrogate for human hepatitis B virus), bovine viral diarrhea virus (BVDV; a surrogate for human hepatitis C virus), and human coxsackie type B3 virus (CB3). SETTING: Public health virology laboratory. METHODS: Studies were performed on the distal, electrode-containing segments of 120 electrophysiology catheters previously used in up to 10 clinical procedures. Catheter segments were immersed for 1 hour in blood infected with high titers of DHBV, BVDV, or CB3. After air drying for 2 hours, subgroups of 8 catheters were subjected to no treatment, washing in general-purpose detergent, washing in enzyme cleaner, sterilization in ethylene oxide, or the full protocol of sequential detergent-enzyme cleaner-ethylene oxide exposure. Presence of residual virus was assessed by nucleic acid detection and infectivity studies. RESULTS: DHBV nucleic acid was detected on catheters after individual steps and the full protocol, whereas BVDV and CB3 nucleic acids were detected after individual steps but not the full protocol. These findings were associated with the presence of infectious DHBV and CB3, but not BVDV, on catheters after washing in detergent or enzyme cleaner. However, ethylene oxide alone or the full protocol reduced infectivity of all three viruses to undetectable levels. CONCLUSION: These experimental studies provide strong evidence that appropriate cleaning and sterilization of reused electrophysiology catheters inactivates blood-borne viruses such as hepatitis B and C and coxsackie type B3.


Subject(s)
Catheterization , Disinfectants/pharmacology , Electrophysiology/instrumentation , Enterovirus B, Human/drug effects , Equipment Reuse , Hepatitis Viruses/drug effects , Sterilization/standards , Enterovirus B, Human/genetics , Hepatitis Viruses/classification , Hepatitis Viruses/genetics , Humans , Nucleic Acids/analysis , Sterilization/methods
4.
Infect Control Hosp Epidemiol ; 24(3): 184-90, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12683509

ABSTRACT

OBJECTIVE: To assess the effect of a standard decontamination and sterilization protocol employed during reuse of cardiac electrophysiology (EP) catheters on human immunodeficiency virus (HIV). SETTING: Public health viral research laboratory. METHODS: Studies were performed on distal, electrode-containing segments of 40 EP catheters previously used in up to 10 clinical EP procedures. EP catheter segments were immersed for 1 hour in blood contaminated with a high titer of HIV. After air drying for 2 hours, subgroups of 8 EP catheters were subjected to either (1) no treatment, (2) washing in general purpose detergent, (3) washing in enzyme cleaner, (4) sterilization in ethylene oxide, or (5) the full protocol of sequential detergent-enzyme cleaner-ethylene oxide exposure. HIV infectivity after treatment was determined by measuring HIV RNA and, in cell culture studies, assessing HIV-induced cytopathic effects (CPEs) and supernatant HIV-specific p24 antigen content RESULTS: With no treatment, all catheters had high HIV RNA levels associated with CPEs and high p24 antigen levels. After washing in detergent, 5 of 8 catheters had HIV RNA detected, but without CPEs or p24 antigen. HIV RNA was detected in all catheters after washing in enzyme cleaner, with CPEs and a high p24 antigen level in 1 of 8 catheters. HIV RNA, CPEs, and p24 antigen were absent after ethylene oxide. After the full protocol, HIV RNA levels were undetectable (n = 7) or low (n = 1), without evidence of CPEs or p24 antigen. CONCLUSION: Appropriate decontamination and sterilization of EP catheters during reuse is highly effective in inactivating HIV.


Subject(s)
Cardiac Catheterization/instrumentation , HIV-1/drug effects , HIV-1/pathogenicity , Infection Control/methods , Sterilization/methods , Antigens, Viral/analysis , Disinfectants , Electrodes , Electrophysiology , Equipment Contamination , Equipment Reuse , Ethylene Oxide , HIV Core Protein p24/analysis , Humans , RNA, Viral/analysis
5.
J Med Chem ; 45(2): 371-81, 2002 Jan 17.
Article in English | MEDLINE | ID: mdl-11784141

ABSTRACT

New amino acids are reported in which component macrocycles are constrained to mimic tripeptides locked in a beta-strand conformation. The novel amino acids involve macrocycles functionalized with both an N- and a C-terminus enabling addition of appendages at either end to modify receptor affinity, selectivity, or membrane permeability. We show that the cycles herein are effective templates within inhibitors of HIV-1 protease. Eleven compounds originating from such bifunctionalized cyclic templates are potent inhibitors of HIV-1 protease (Ki 0.3-50 nM; pH 6.5, I = 0.1 M). Unlike normal peptides comprising amino acids, five of these macrocycle-containing compounds are potent antiviral agents with sub-micromolar potencies (IC(50) 170-900 nM) against HIV-1 replication in human MT2 cells. The most active antiviral agents are the most lipophilic, with calculated values of LogD(6.5) > or = 4. All molecules have a conformationally constrained 17-membered macrocyclic ring that has been shown to structurally mimic a tripeptide segment (Xaa)-(Val/Ile)-(Phe/Tyr) of a peptide substrate in the extended conformation. The presence of two trans amide bonds and a para-substituted aromatic ring prevents intramolecular hydrogen bonds and fixes the macrocycle in the extended conformation. Similarly constrained macrocycles may be useful templates for the creation of inhibitors for the many other proteins and proteases that recognize peptide beta-strands.


Subject(s)
Amino Acids/chemical synthesis , Anti-HIV Agents/chemical synthesis , HIV Protease Inhibitors/chemical synthesis , HIV-1 , Oligopeptides/chemistry , Peptides, Cyclic/chemical synthesis , Amino Acids/chemistry , Amino Acids/pharmacology , Anti-HIV Agents/chemistry , Anti-HIV Agents/pharmacology , Cell Line , Cytopathogenic Effect, Viral , HIV Protease Inhibitors/chemistry , HIV Protease Inhibitors/pharmacology , Humans , Models, Molecular , Peptides, Cyclic/chemistry , Peptides, Cyclic/pharmacology , Protein Structure, Secondary
6.
J Gen Virol ; 81(Pt 10): 2511-2518, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10993941

ABSTRACT

Molecular epidemiology studies have made significant contributions to the control of measles virus infection through the identification of source and transmission pathways of the virus. These studies allow observation of changes in measles virus genotypes over time in a particular geographical location, clarification of epidemiological links during measles outbreaks, separation of indigenous strains from newly imported strains and distinction between vaccine- and wild-type virus-associated illness. A total of 35 wild-type measles viruses identified in Victoria, Australia, between 1973 and 1998 were characterized by nucleic acid sequence analysis of the nucleoprotein gene and, in some cases, the haemagglutinin gene. Relatedness between the viruses was studied and genotypes were assigned using a classification scheme recently proposed by the World Health Organization. Five recognized genotypes (C2, D1, D4, D5 and H) and one previously undescribed genotype, which we propose to be D7, were identified. Successive replacement of measles virus genetic lineages occurred in Victoria, with no evidence of temporal overlap, during this 25 year period. This pattern of circulation is likely to represent serial importation of wild-type measles virus strains from overseas foci of measles virus infections.


Subject(s)
Disease Outbreaks , Measles virus/genetics , Measles/epidemiology , Adolescent , Adult , Australia/epidemiology , Base Sequence , Child , Child, Preschool , DNA, Viral/chemistry , Female , Genotype , Humans , Infant , Male , Measles virus/classification , Measles virus/isolation & purification , Molecular Sequence Data , Nucleocapsid Proteins/chemistry , Nucleocapsid Proteins/genetics , Phylogeny , Sequence Analysis, DNA , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...